Mouse models suggest that ALS progression is driven by cellular senescence, as disease progression was correlated with the expression of cellular senescence markers (p16INK4a, p21, and SA-β-Gal) in microglia, astrocytes, and spinal motor neurons [78]. Here, CDKN2A is linked to amyotrophic lateral sclerosis.